Streetbeat News

Regulatory

TOPS

Trading of TOP Ships Inc. (TOPS) has been halted pending news. Investors are awaiting further information that could significantly impact the stock price.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:25 pm

ACIU

AC Immune shares are trading higher after the company's ACI-35.030 was granted FDA Fast Track Designation for Alzheimer's Disease.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:10 pm

TTEK

Tetra Tech, Inc. (NASDAQ:TTEK) has been selected by the U.S. Department of Defense Environmental Security Technology Certification Program to design and test a mobile treatment technology for PFAS-impacted soils and sediments.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:05 pm

GLYC

GlycoMimetics (GLYC) will conduct an additional clinical trial for Uproleselan in relapsed/refractory acute myeloid leukemia (AML) following an FDA meeting. The company is initiating a strategic review and corporate restructuring, reducing its workforce by 80%. GlycoMimetics has engaged Lucid Capital Markets as a strategic advisor and is advancing a Phase 2/3 study of Uproleselan in newly diagnosed AML patients with the NCI and Alliance for Clinical Trials. The company's cash is expected to fund operations into Q2 2025.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 1:01 pm

SNES

Trading halt status for SNES was updated at 8:55:00 AM ET. The halt was due to pending news and the resumption times were provided.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:55 pm

EZFL

Trading for EZFL was halted and then resumed at 8:55:00 AM ET. The halt was due to pending news, and trading resumed after the news was released.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:55 pm

ATNM

Actinium Pharmaceuticals has received FDA clearance for its IND application to study Iomab-ACT as a targeted conditioning agent before bone marrow transplants in sickle cell disease patients. The company is collaborating with Columbia University to expand access to cellular therapies and inform gene therapy conditioning studies.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:48 pm

SGBX

Safe & Green Holdings Corp. (NASDAQ:SGBX) has received an extension until November 12, 2024, to meet Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company plans to achieve compliance through recent private placements, cost-cutting measures, debt reduction, and other strategic initiatives.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:44 pm

CYBR

CyberArk announced that DPD Czech has implemented the CyberArk Identity Security Platform to enhance privileged access security and streamline user access. The project, in partnership with AMI Praha, meets audit and regulatory requirements, including NIS2.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:41 pm

ADTX

APLIF

Aditxt, Inc. (NASDAQ:ADTX) has signed a second amendment to its arrangement agreement with Appili Therapeutics Inc. (TSX:APLI, OTC:APLIF), targeting a September 30, 2024, closing for the acquisition. Appili has raised CAD $100M for developing therapeutics for infectious diseases and biodefense markets, with two programs potentially eligible for FDA Priority Review Vouchers.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 12:37 pm